Garvan Institute, Sydney
After-dinner drink proves beneficial to postmenopausal women
Published in Healthcare Mergers, Acquisitions and Ventures Week, March 19th, 2005
These findings, published in the February 2005 issue of the Journal of Clinical Endocrinology & Metabolism, may explain the decreased risk of heart disease, diabetes, and obesity in people who drink alcohol in moderation.
Previous studies have shown that healthy people who drink small amounts of alcohol regularly have a smaller risk of developing heart disease and diabetes compared to people who either don't drink or drink in excess. Although significant research has been conducted to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- AEterna Zentaris, Inc.
AEterna Zentaris subsidiary files preliminary prospectus for IPO - AFP Imaging Corporation
Imaging company reports record profitable second quarter - Abortion
Bill would require viewing graphic photos before abortion - Accentia Biopharmaceuticals, Inc.
Biopharmaceutical company reports plans for initial public offering - Advanced Neuromodulation Systems, Inc.
Medical device firm reports 26% increase in fourth quarter revenue - Advanced Nutraceuticals, Inc.
Nutraceutical company reports income of $0.08 per share - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
